RPMI-1640

文献(776)

一键复制产品信息

货号： PM150110

Size：

500 mL

产品信息

产品简介	RPMI-1640是Moore等人于1967年在美国纽约州法罗市的罗斯韦尔公园纪念研究所（Roswell Park Memorial Institute, RPMI）开发出来的，RPMI是该研究所开发的一类细胞培养基，1640是培养基代号。RPMI-1640是改进型的McCoy's 5A培养基，使用碳酸氢盐缓冲系统，与大多数哺乳动物细胞培养基不同的是其典型的PH8的配方。RPMI-1640培养基最初是为淋巴细胞培养专门设计的，现在已广泛应用于各种正常细胞和癌细胞的培养，尤其是悬浮细胞的培养，是使用最为广泛的培养基之一。本产品含有多类细胞培养所需的氨基酸、维生素、无机盐等多种成分，但不含蛋白质、脂类或任何生长因子，故此产品需搭配血清或无血清添加物使用。
产品浓度	1×
产品规格	500 mL
PH	7.2-7.4
D-葡萄糖	2000mg/L
HEPES	无
L-谷氨酰胺	2mM
NaHCO3	2000mg/L
酚红	5mg/L
内毒素含量(EU/mL)	＜3
储存条件	2-8℃，避光储存
运输条件	常温
注意事项	1.本产品经0.1 μm过滤除菌，使用时应注意无菌操作，避免污染； 2.为保持本产品的最佳使用效果，请勿进行冻融处理； 3.本产品仅用于科研或进一步研究使用，不用于诊断和治疗。

Association between the Reduced Expression of RECK and Neutrophilic Inflammation in Chronic Obstructive Pulmonary Disease(2024)

期刊：INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

DOI：10.1159/000536021

影响因子：2.500

引用产品： RPMI-1640 Medium
A novel therapeutic strategy for leukopenia: Miltefosine activates the Ras/MEK/ERK pathway to promote neutrophil differentiation(2024)

期刊：BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

DOI：10.1016/j.bbrc.2024.151239

影响因子：2.500

引用产品： IMDM Medium, RPMI-1640 Medium
ZNF217 Mediates Transcriptional Activation of GRHL3 to Regulate SLC22A31 and Promote Malignant Progression in Thyroid Cancer(2024)

期刊：MOLECULAR BIOTECHNOLOGY

DOI：10.1007/s12033-024-01292-6

影响因子：2.400

引用产品： SW579 [SW 579; SW-579] Cells Line, RPMI-1640 Medium, Nthy-ori 3-1 Cells Line, TPC-1 Cells Line, Leibovitz's L-15 Medium
A Cuproptosis-Related gene Signature as a Prognostic Biomarker in Thyroid Cancer Based on Transcriptomics(2024)

期刊：BIOCHEMICAL GENETICS

DOI：10.1007/s10528-024-10767-9

影响因子：2.400

引用产品： FTC-133 Cells Line, RPMI-1640 Medium, TPC-1 Cells Line, Nthy-ori 3-1 Cells Line
N6-Methyladenosine Modification of PERP by RBM15 Enhances the Tumorigenesis of Lung Adenocarcinoma via p53 Signaling Pathway(2024)

期刊：MOLECULAR BIOTECHNOLOGY

DOI：10.1007/s12033-024-01323-2

影响因子：2.400

引用产品： Fetal Bovine Serum, RPMI-1640 Medium, A549 [A-549] Cells Line, PC-9 Cells Line, Ham's F-12K Medium
EIF4A3-Induced hsa_circ_0118578 Expression Enhances the Tumorigenesis of Papillary Thyroid Cancer(2024)

期刊：CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

DOI：10.1089/cbr.2024.0133

影响因子：2.400

引用产品： TPC-1 Cells Line, RPMI-1640 Medium, Fetal Bovine Serum, Human Thyroid Follicular Epithelial Cells, KTC-1 Cells Line, Human Thyroid Follicular Epithelial Cell Complete Medium
Anti-cancer effects of Coix seed extract through KCTD9-mediated ubiquitination of TOP2A in lung adenocarcinoma(2024)

期刊：Cell Division

DOI：10.1186/s13008-024-00112-2

影响因子：2.300

引用产品： A549 [A-549] Cells Complete Medium, Ham's F-12K, HCC827 Cells Complete Medium, RPMI-1640
HPV-driven heterogeneity in cervical cancer: study on the role of epithelial cells and myofibroblasts in the tumor progression based on single-cell RNA sequencing analysis(2024)

期刊：PeerJ

DOI：10.7717/peerj.18158

影响因子：2.300

引用产品： RPMI-1640 Medium, Penicillin-Streptomycin Solution, 100 ×, Hela Cells Line, Fetal Bovine Serum, Human Cervical Epithelial Cells, MEM, with NEAA Medium
USP22 promotes gefitinib resistance and inhibits ferroptosis in non-small cell lung cancer by deubiquitination of MDM2(2024)

期刊：Thoracic Cancer

DOI：10.1111/1759-7714.15439

影响因子：2.300

引用产品： HCC827 Cells Line, PC-9 Cells Line, RPMI-1640 Medium, Penicillin-Streptomycin Solution, 100 ×, Fetal Bovine Serum
CircRNA ATF6 suppresses bladder cancer cell proliferation and migration via miR-146a-5p/FLNA axis(2024)

期刊：MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

DOI：10.1016/j.mrfmmm.2024.111876

影响因子：2.300

引用产品： RT4 Cells Line, SV-HUC-1 Cells Line, Penicillin-Streptomycin Solution, 100 ×, 293T [HEK-293T] Cells Line, MEM, with NEAA Medium, DMEM (High glucose) Medium, J82 Cells Line, Ham's F-12K Medium, T24 [T-24] Cells Line, McCoy's 5A Medium, 5637 Cells Line, RPMI-1640 Medium, Fetal Bovine Serum